Advanced search
Publication Cover
Neuro-Ophthalmology Volume 33, 2009 - Issue 6
Submit an article Journal homepage
35
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Acute Pre-ganglionic Horner Syndrome Positive to Apraclonidine Test

Dália MeiraCentro Hospitalar de Vila Nova de Gaia/Espinho EPE – PortugalCorrespondence[email protected]
,
Lígia RibeiroCentro Hospitalar de Vila Nova de Gaia/Espinho EPE – Portugal
&
Carlos AredeCentro Hospitalar de Vila Nova de Gaia/Espinho EPE – Portugal
Pages 333-335 | Received 28 Jul 2009, Accepted 23 Aug 2009, Published online: 08 Dec 2009

REFERENCES

  • Miller NR, Newman NJ, Biousse V, Kerrison JB. et al. Walsh and Hoyt’s Clinical Neuro-Ophthalmology 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2005:749–753.
  • Walton AK, Buono LM. Horner syndrome. Curr Opin Ophthalmol 2003;14:357–363.
  • Kaya SO, Liman SL, Bir LS, Yuncun G, Erbay HR. Horner’s syndrome as a complication in thoracic surgical practice. Eur J Cardiothorac Surg 2003;24:1025–1028.
  • Levy M, Newman-Toker D. Reversible chest tube Horner syndrome. J Neuroophthalmol 2008;28:212–213.
  • Morales J, Brown SM, Abdul-Rahim AS, Crosson CE. Ocular effects of apraclonidine in Horner syndrome. Arch Ophthalmol 2000;118:951–954.
  • Brown S, Aouchiche R, Freedman KA. The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome. Arch Ophthalmol 2003;121:1201–1203.
  • Bacal DA, Conn M, Levy SR, Conn G. The use of apraclonidine in the diagnosis of Horner syndrome in pediatric patients. Arch Ophthalmol 2004;122:276–279.
  • Freedman KA, Brown SM. Topical apraclonidine in the diagnosis of suspected Horner syndrome. J Neuroophthalmol 2005;25:83–85.
  • Koc F, Kavuncu S, Kansu T Acaroglu G, Firat E. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Br J Ophthalmol 2005;89:1442–1444.
  • Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination. Am J Ophthalmol 2006;142:469–474.
  • Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY. Comparising efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of Horner syndrome in pediatric patients. J Ocul Pharmacol Ther 2006;22:182–187.
  • Garibaldi DC, Hindman HB, Grant MP, Iliff NT, Merbs SL. Effect of 0.5% apraclonidine on ptosis in Horner syndrome. Ophthal Plast Reconstr Surg 2006;22:53–55.
  • Bohnsack BL, Parker JW. Positive apraclonidine test within two weeks of onset of Horner syndrome caused by carotid artery dissection. J Neuro-Ophthalmol 2008; 28:235–236.
  • Dewan MA, Harrison AR, Lee MS. False-negative apraclonidine testing in acute Horner syndrome. Can J Ophthalmol 2009;44(1):109–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.